Scarica l'app Stockscreener
27.58
0.40%
0.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Public Sector Pension Investment Board Grows Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE - MarketBeat
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings - Finviz
Pfizer Advances VESPER-5 Obesity and Diabetes Trial, Targeting a Key Growth Market - TipRanks
Fund Update: 753,189 PFIZER (PFE) shares added to THORNBURG INVESTMENT MANAGEMENT INC portfolio - Quiver Quantitative
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? - Insider Monkey
Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate - simplywall.st
Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - Yahoo Finance
Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America - MarketBeat
Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 - The Motley Fool
Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc - MarketBeat
Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - MarketBeat
Illinois Municipal Retirement Fund Cuts Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer (PFE) Sees Mixed Options Sentiment Amid Stock Downgrade - GuruFocus
Glioblastoma Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics - Barchart.com
Varma Mutual Pension Insurance Co Purchases 82,500 Shares of Pfizer Inc. $PFE - MarketBeat
ING Groep NV Lowers Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by LSV Asset Management - MarketBeat
Pfizer (NYSE:PFE) Cut to Neutral at Daiwa Securities Group - MarketBeat
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More - 24/7 Wall St.
Madison Asset Management LLC Has $6.17 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Shares Hit Annual Peak on Regulatory and Strategic Momentum - AD HOC NEWS
Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… - marketscreener.com
Caprock Group LLC Makes New Investment in Pfizer Inc. $PFE - MarketBeat
Daiwa Securities Downgrades Pfizer to Neutral From Outperform, Price Target is $27 - marketscreener.com
Pfizer Hemophilia And Obesity Updates Reshape Growth And Valuation Outlook - Yahoo! Finance Canada
Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute - Law360
Pfizer: A Great Opportunity Post Earnings (NYSE:PFE) - Seeking Alpha
Pfizer, SEC Reach $29M End to Scrap Over Insider Trading Settlement - Law.com
Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships - simplywall.st
Is Now the Best Time to Buy Pfizer Stock? - The Globe and Mail
Pfizer Reports Strong Earnings OutlookUnusual Call Options Activity Shows Investors are Bullish - Yahoo Finance
Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders - Finviz
Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? - The Globe and Mail
Is Pfizer Stock Now A Value Trap? - Forbes
Wealthfront Advisers LLC Has $14.76 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Oppenheimer Asset Management Inc. - MarketBeat
Enzyme Inhibitors Market Is Going to Boom |• Pfizer • Merck & Co. - openPR.com
Is Pfizer Stock Heading for a Fall? - Trefis
Pfizer Inc. $PFE Shares Bought by Advisors Asset Management Inc. - MarketBeat
Can Pfizer Stock Withstand These Pressures? - Trefis
Pfizer Gets $29 Million of SAC Capital Insider Trade SEC Payout - Bloomberg Law News
Pfizer (NYSE:PFE) Shares Up 2.1%Still a Buy? - MarketBeat
Pfizer (NYSE:PFE) Sets New 1-Year HighStill a Buy? - MarketBeat
Pfizer stock hits 52-week high at 27.7 USD - Investing.com
Pfizer stock jumps as PFE taps a Swiss biotech incubator — here’s what Wall Street is watching next - Bez Kabli
Smart Money Is Betting Big In PFE Options - Benzinga
Pfizer Inc. (PFE) is a trending stock: Facts to know before betting on it - MSN
Pfizer Inc. (PFE) Announces FDA’s Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA - Yahoo Finance
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Pfizer Becomes Newest Partner Added to BaseLaunch's Biotech Venture Incubator - Yahoo Finance
Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI (marstacimab) sBLA - Finviz
5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call - The Globe and Mail
5 Revealing Analyst Questions From Pfizer's Q4 Earnings Call - Finviz
BridgePort Financial Solutions LLC Has $3.35 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Stock Watch: Pfizer Navigates Vaccine Gains And Acquisition Pains - Citeline News & Insights
Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20% - The Economic Times
Pfizer Balances TrumpRx Drug Discounts And HYMPAVZI Review With Valuation Gap - Yahoo Finance UK
Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend? - Nasdaq
Pfizer (PFE) Tied to Drug Listings on Emerging TrumpRx Platform - GuruFocus
Freedom Capital Markets lowers Pfizer stock price target to $33 on COVID unwind - Investing.com
Indiana wins settlement for $6.25 million with global pharmaceutical companies over alleged conspiracy to increase EpiPen prices - WTHR
Entera Bio appoints former Pfizer executive Geno J. Germano as chairman of the board ahead of key milestones - marketscreener.com
Pfizer-backed firm advances potential billion-dollar drug for rare skin disease - The Business Journals
Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? - The Globe and Mail
Entera Bio Attracts Former Pfizer Group President as It Enters a New Phase (NASDAQ: ENTX) - GuruFocus
Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care - Bioscience Association Manitoba
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):